Social Characteristics of Hospitalized Patients With Spinal Degenerative Diseases

July 2, 2021 updated by: Peking University Third Hospital

An Analysis of Social Characteristics of Hospitalized Patients With Spinal Degenerative Diseases in the Orthopedic Department of Peking University Third Hospital During 2003-2016

To explore the correlation of the incidence and social characteristics in patients with spinal degenerative diseases (SDD), and to provide certain evidence for prevention, treatment and incidence control of the disease.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Objectives: To explore the correlation of the incidence and social characteristics in patients withspinal degenerative diseases (SDD), and to provide certain evidence for prevention, treatment and incidencecontrol of the disease. Methods: Data between January 1, 2003 to December 31, 2016 were collected from electronic medical documents of the orthopedic department, including patients who suffered from SDD, treated by operation for the first time and aged 18 years old or over. Descriptive statistics and Chi-square test were used to analyze the correlation of social characteristics of patients（eg. age, gender, career, place of birth, nationality and comorbidities）and the degenerative spinal diseases.

Study Type

Observational

Enrollment (Actual)

32502

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Beijing
      • Beijing, Beijing, China, 100191
        • Peking University Third Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

A total of 32522 surgical inpatients were selected from Peking University Third Hospital during 2003-2016.

Description

Inclusion Criteria:

  1. Diagnosed as spinal disc herniation (prolapse), spinal stenosis, Non-traumatic spinal instability, spondylolisthesis, degenerative scoliosis not caused by congenital spinal deformity. 2. Hospitalized patients under operation. 3. Over 18 yrs. 4. Patients in North China.

Exclusion Criteria:

- Patients diagnosed as Hypertrophy of Posterior Longitudinal Ligament or Hypertrophy of Ligamentum Flavum.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients diagnosed with Cervical Degenerative Disease
Patients who suffered from Cervical Degenerative Disease, treated by operation for the first time and aged 18 years old or over were assigned to CDD group.
Other: Without additional intervention
Only patients' information was collected
Patients diagnosed with Thoracic Degenerative Disease
Patients who suffered from Thoracic Degenerative Disease, treated by operation for the first time and aged 18 years old or over were assigned to TDD group.
Other: Without additional intervention
Only patients' information was collected
Patients diagnosed with Lumbar Degenerative Disease
Patients who suffered from Lumbar Degenerative Disease, treated by operation for the first time and aged 18 years old or over were assigned to LDD group.
Other: Without additional intervention
Only patients' information was collected

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Population characteristics of hospitalized patients
Time Frame: 2003-2016
Correlation analysis of population characteristics and spinal degenerative diseases (SDD)
2003-2016

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Peking University Third Hospital

Investigators

  • Principal Investigator: Yan Li, M.D., Peking University Third Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

August 1, 2018

Primary Completion (ACTUAL)

August 30, 2018

Study Completion (ACTUAL)

October 23, 2018

Study Registration Dates

First Submitted

July 2, 2021

First Submitted That Met QC Criteria

July 2, 2021

First Posted (ACTUAL)

July 9, 2021

Study Record Updates

Last Update Posted (ACTUAL)

July 9, 2021

Last Update Submitted That Met QC Criteria

July 2, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • M2018082

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Degenerative Diseases

Clinical Trials on Without additional intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe